The global endoscopes market size was valued at USD 10.4 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of8.8% from 2020 to 2027. Increasing geriatric population, growing awareness of the benefits of minimally invasive surgeries over open invasive surgeries, rising prevalence of chronic diseases such as heart diseases, cancer, and diabetes drive the market. Various technological advancements are also among the key trends boosting the demand for endoscopes globally.
Minimally invasive surgeries are driving the use of various endoscopic procedures for diagnosis such as proctoscopy, gastroscopy, and cystoscopy. These surgeries require smaller incisions and hence offer advantages such as lesser pain, low or no risk of complications, and quicker recovery when compared to open surgery. Minimally invasive surgeries are also cost-effective and result in improved quality of life. The shift in trend from open surgery to minimally invasive procedures is expected to drive the demand for endoscopes.
Increasing prevalence of cancer is one of the key factors contributing to the growth of the market. The growing prevalence of cancer is expected to drive the demand for biopsies in cancer diagnosis. Endoscopy for biopsies and endoscopic ultrasound are the most preferred procedures for cancer diagnosis. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018, which is estimated to increase to 22.0 million by 2034.
Emergence of endoscopic bariatric surgeries, namely, endoscopic sleeve gastroplasty is also expected to drive the market growth. This procedure uses sutures for restructuring the stomach and helps reduce the stomach size by 70.0%. Although weight loss due to endoscopic bariatric surgery is not as effective as a surgical bariatric procedure, the former results in better health outcomes. Thus, the rise in demand for bariatric procedures is further expected to drive the demand for endoscopes.
Owing to the effects of aging and the adoption of unhealthy lifestyles, disease burden is highest in geriatric patients. Furthermore, the geriatric population accounts for the maximum cases of cancer and chronic cardiovascular, respiratory, spinal, and neurological diseases. The economic impact of the geriatric population is much higher in developed nations as compared to emerging nations. The growing geriatric population is expected to boost the demand for various endoscopic procedures such as stomach, esophagus, cervical, orthopedic, and pulmonary endoscopy, subsequently driving the demand for endoscopes.
In 2019, flexible endoscopes held the largest market share of 51.0% of the global endoscopes market. Their ergonomics features, increased safety and efficiency, and advancements in medical-optics technology drive the demand and consumption of flexible endoscopes. Increasing adoption of micro endoscopes, coupled with the rising trend of manufacturing smaller endoscopic devices, and consumer shift in preference to High Definition (HD) and 3D systems are likely to boost the demand for flexible endoscopes globally. Moreover, several training centers have been set up to train medical professionals on using advanced flexible endoscopes, which drives the segment growth.
Key market players focus on R&D initiatives to improvise their existing products as well as launch new technologically advanced products. For instance, Auris Health, Inc. received the Food and Drug Administration (FDA) approval for its new robotic endoscopy system-Monarch Platform-in 2018.
Among different types of flexible endoscopes, upper gastrointestinal endoscopes accounted for a significant share in 2019. According to GLOBOCAN, a project of the International Agency for Research on Cancer, gastric cancer accounted for approximately 783,000 deaths in 2018. Widening pool for patients suffering from gastric cancer and increasing demand for cancer screening are contributing to the growth of this segment. Various initiatives are undertaken by governments to create awareness regarding cancer detection and its diagnosis also drives the demand for different endoscopes. For instance, in 1986, a ‘Cancer Care for Life’ scheme was launched in order to generate a welfare fund for cancer patients.
On the other hand, the disposable endoscopes segment is expected to grow at a high rate over the forecast period on account of the increasing demand for single-use scopes for eliminating the risk of device-related infections. Device-related infections is a major health concern globally. According to the U.S. FDA estimates (2016), nearly 350 patients from 41 medical facilities in U.S. were exposed to or infected by contaminated gastroscopes. Disposable endoscopes are also more cost-effective than reusable endoscopes, further driving its usage. Some of the market players have invested in the development of single-use endoscopes such as disposable bronchoscopes, disposable arthroscopes, and disposable gastroscopes.
In 2019, Gastrointestinal (GI) endoscopy emerged as the largest application segment, mainly owing to an increase in the number of gastroscopies, rise in adoption of endoscopes for diagnosis as well as treatment of GI diseases, and availability of advanced products for gastroscopy. According to the Centers for Disease Control and Prevention (CDC), in U.S., nearly 14.8 million people were diagnosed with ulcers in 2015, thereby increasing the adoption of gastroscopies for diagnosis. The presence of organizations such as United European Gastroenterology that are dedicated to raise awareness about GI disorders and promote research initiatives to reduce the burden of GI diseases is also driving the growth of the endoscopes market.
In addition, advancements in optical imaging systems is expected to drive the adoption of flexible endoscopes in neuroendoscopy. Key players are conducting a number of programs to raise awareness about emerging neuroendoscopy techniques, which, in turn, influences the adoption rate of endoscopic devices for neurosurgeries. The growing prevalence of various cardiovascular diseases and the subsequent rise in diagnosis and treatment procedures lead to a higher usage rate of endoscopes in various cardiovascular surgeries.
The urology endoscopy segment is projected to grow at the highest rate over the forecast period. According to a report published by the American Cancer Society in 2018, nearly 75,000 Americans are diagnosed with bladder cancer every year. It was estimated that 81,190 new cases of bladder cancer would be diagnosed by the end of 2018. Growing risk of urinary disorders; increasing prevalence of hematuria, urinary tract stones, bladder cancer; and rise in the aging population are key factors that would drive the segment over the forecast period.
In 2019, hospitals emerged as the largest end-use segment owing to large-scale adoption of endoscopes and an increase in the number of surgeries performed in hospitals. Favorable reimbursement policies for patients who visit hospitals as compared to those seeking treatment at ambulatory centers and the presence of a large number of hospitals and primary care centers in both developed and developing economies are the key factors driving the demand for endoscopes for procedures conducted in hospitals.
The ambulatory surgery centers (ASCs) segment is anticipated to witness the highest growth rate over the forecast period. Increase in preference for minimally invasive surgeries and reduced hospital stays are some of the key factors identified as drivers for the growing demand for endoscopic surgeries at ASCs. There is a growing trend of same day surgery, which results in significant cost savings and optimum care delivery in developed economies. Furthermore, time efficiency, minimal discomfort owing to the introduction of keyhole surgeries, and quick recovery time are some of the key factors driving the demand for endoscopic surgeries in ambulatory surgical centers, thereby positively impacting the market growth.
North America dominated the market with a share of over 40.0% in 2019. This is attributed to developed healthcare infrastructure, high adoption of advanced technologies, and an increase in awareness about the advantages of minimally invasive therapies. High incidences of obesity and growing demand for minimally invasive bariatric surgeries are also some of the key drivers expected to positively affect the market. Moreover, the presence of organizations such as American Society for Gastrointestinal Endoscopy, which is dedicated to patient care and digestive health for promoting innovations in endoscopy is expected to boost market growth.
A rise in the geriatric population and an increase in burden of chronic diseases such as cancer and GI diseases are driving the market growth in Europe. Moreover, technological advancements such as the development of microendoscopic and robot-assisted surgeries are driving the regional market growth. Various initiatives are undertaken by United European Gastroenterology (UEG) and European Society of Gastrointestinal Endoscopy (ESGE) for creating supportive endoscopy services communities across Europe and promoting collaboration for providing safe, patient-centered, and accessible endoscopic care is expected to positively impact the market growth.
Asia Pacific is anticipated to be the fastest-growing market over the forecast period. Improving healthcare infrastructure, coupled with economic development in this region, has attracted foreign investments. Thus, key market players are developing strategies for expanding their business in this region. Moreover, rise in awareness about the advantages of minimally invasive surgeries over open surgeries and high chronic disease burden are expected to provide growth opportunities in this region. Aging population, particularly in China, is expected to further drive the market growth.
Olympus accounted for a share of approximately 70.0% in GI endoscopy. Mergers, acquisitions, significant investments in R&D, and the development of new products or product modifications are among the key strategies adopted by market players to gain a competitive edge. Some of the prominent players in the endoscopes market include:
Hormel Foods Corporation
Stokely-Van Comp, Inc.
Market size value in 2020
USD 11.29 billion
Revenue forecast in 2027
USD 20.37 billion
CAGR of 8.8% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD million and CAGR from 2020 to 2027
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, end use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Switzerland; Denmark; Japan; China; India; Australia; New Zealand; Thailand; Indonesia; Malaysia; Vietnam; Philippines; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait; Israel; Qatar
Key companies profiled
Olympus; Richard Wolf GmbH; Fujifilm Holdings Corporation; Karl Storz
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research, Inc. has segmented the global endoscopes market report on the basis of product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2027)
Other Rigid Endoscopes
Upper Gastrointestinal Endoscopes
Other Flexible Endoscopes
Robot Assisted Endoscopes
Application Outlook (Revenue, USD Million, 2016 - 2027)
Gastrointestinal (GI) Endoscopy
Obstetrics/ Gynecology Endoscopy
Urology Endoscopy (Cystoscopy)
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Ambulatory Surgery Centers
Other End Uses
Regional Outlook (Revenue, USD Million, 2016 - 2027)
Middle East & Africa
b. The global endoscopes market size was estimated at USD 10.38 billion in 2019 and is expected to reach USD 11.29 billion in 2020.
b. The global endoscopes market is expected to grow at a compound annual growth rate of 8.8% from 2019 to 2027 to reach USD 20.37 billion by 2027.
b. Flexible endoscopes dominated the endoscopes market with a share of 51.0% in 2019. This is attributable to their ergonomics features, increased safety, efficiency, and advancements in medical-optics technology thus driving the demand and consumption of flexible endoscopes.
b. Some key players operating in the endoscopes market include Fujifilm Holdings Corporation; Olympus Corporation LLC; Stryker Corporation; Ethicon Endo-Surgery; Richard Wolf GmbH; Karl Storz; and Boston Scientific Corporation.
b. Key factors that are driving the market growth include increasing geriatric population; growing preference for minimally invasive surgeries; and a rise in incidences of cancer, gastrointestinal diseases, and other chronic diseases.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.